The Effects of Dextromethorphan on Driving Performance and the Standardized Field Sobriety Test.

Citation data:

Journal of forensic sciences, ISSN: 1556-4029, Vol: 60, Issue: 5, Page: 1258-62

Publication Year:
2015
Usage 190
Abstract Views 137
Link-outs 29
Full Text Views 24
Captures 34
Exports-Saves 22
Readers 12
Social Media 1
Tweets 1
Citations 2
Citation Indexes 2
PMID:
26294136
DOI:
10.1111/1556-4029.12833
Author(s):
Perry, Paul J; Fredriksen, Kristian; Chew, Stephanie; Ip, Eric J; Lopes, Ingrid; Doroudgar, Shadi; Thomas, Kelan
Publisher(s):
Wiley-Blackwell
Tags:
Medicine; Biochemistry, Genetics and Molecular Biology
Most Recent Tweet View All Tweets
article description
Dextromethorphan (DXM) is abused most commonly among adolescents as a recreational drug to generate a dissociative experience. The objective of the study was to assess driving with and without DXM ingestion. The effects of one-time maximum daily doses of DXM 120 mg versus a guaifenesin 400 mg dose were compared among 40 healthy subjects using a crossover design. Subjects' ability to drive was assessed by their performance in a driving simulator (STISIM® Drive driving simulator software) and by conducting a standardized field sobriety test (SFST) administered 1-h postdrug administration. The one-time dose of DXM 120 mg did not demonstrate driving impairment on the STISIM® Drive driving simulator or increase SFST failures compared to guaifenesin 400 mg. Doses greater than the currently recommended maximum daily dose of 120 mg are necessary to perturb driving behavior.